Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypothalamic Diseases”

1,023 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,023 results

Not applicableWithdrawnNCT06113952
What this trial is testing

Compare the Experiences of Taking Daily Growth Hormone Injections to Weekly Ngenla in Children With Low Levels of Growth Hormone

Who this might be right for
Pediatric Growth Hormone Deficiency
Pfizer
Not applicableLooking for participantsNCT00599092
What this trial is testing

Pituitary Tumor Surveillance: Pathogenic Correlation

Who this might be right for
Pituitary Tumor
Cedars-Sinai Medical Center 1,250
Large-scale testing (Phase 3)Study completedNCT00102817
What this trial is testing

Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children

Who this might be right for
Growth Hormone DisorderPituitary Dwarfism
Novo Nordisk A/S 149
Not applicableEnded earlyNCT04146389
What this trial is testing

Hyperprolactinemia and Adrenal Steroidogenesis

Who this might be right for
Hyperprolactinemia
Insel Gruppe AG, University Hospital Bern 5
Post-approval studies (Phase 4)UnknownNCT02314676
What this trial is testing

Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children

Who this might be right for
Dwarfism, Pituitary
Changchun GeneScience Pharmaceutical Co., Ltd. 900
Post-approval studies (Phase 4)Study completedNCT00360074
What this trial is testing

Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation

Who this might be right for
Secondary HypothyroidismHypopituitarismHyperlipidemias
University Hospital Freiburg 25
Not applicableEnded earlyNCT00504218
What this trial is testing

Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant Recipients

Who this might be right for
HypopituitarismHypogonadismThyroid Dysfunction+1 more
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 62
Large-scale testing (Phase 3)Ended earlyNCT00765323
What this trial is testing

Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly

Who this might be right for
Acromegaly
Endo Pharmaceuticals 169
Early research (Phase 1)Study completedNCT00036959
What this trial is testing

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more
National Institutes of Health Clinical Center (CC) 90
Testing effectiveness (Phase 2)Study completedNCT00004078
What this trial is testing

Irinotecan in Treating Children With Refractory Solid Tumors

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood Craniopharyngioma+18 more
Children's Oncology Group 181
Post-approval studies (Phase 4)UnknownNCT01742390
What this trial is testing

Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders

Who this might be right for
Sexual DysfunctionHyperprolactinemia
Si Tianmei 120
Post-approval studies (Phase 4)UnknownNCT02380235
What this trial is testing

Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I)

Who this might be right for
Growth Hormone Deficiency
Changchun GeneScience Pharmaceutical Co., Ltd. 600
Large-scale testing (Phase 3)Study completedNCT01137682
What this trial is testing

Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly

Who this might be right for
Acromegaly
Novartis Pharmaceuticals 198
Not applicableStudy completedNCT05448924
What this trial is testing

Isolated Growth Hormone Deficiency and Amennorrhea

Who this might be right for
Growth Hormone Deficiency
Universitas Padjadjaran 1
Not applicableLooking for participantsNCT06949891
What this trial is testing

KETOgenic Diet Therapy in Patients With ACROmegaly

Who this might be right for
Acromegaly Due to Pituitary AdenomaKetogenic DietMediterranean Diet
Erasmus Medical Center 60
Not applicableStudy completedNCT05070091
What this trial is testing

The Impact of Pituitary-thyroid and Pituitary-adrenal Axes Function on COVID-19 Clinical Course.

Who this might be right for
COVID-19Low Triiodothyronine SyndromeAdrenal Insufficiency+3 more
Medical University of Gdansk 180
Post-approval studies (Phase 4)Study completedNCT01618513
What this trial is testing

Treatment of Acromegaly With Somatostatin Analogs: GH vs. IGF-I as Primary Biochemical Target

Who this might be right for
Acromegaly
University of Aarhus 84
Not applicableLooking for participantsNCT02435940
What this trial is testing

Inherited Retinal Degenerative Disease Registry

Who this might be right for
Eye Diseases HereditaryRetinal DiseaseAchromatopsia+25 more
Foundation Fighting Blindness 20,000
Early research (Phase 1)Ended earlyNCT00238173
What this trial is testing

Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ+1 more
OHSU Knight Cancer Institute 2
Testing effectiveness (Phase 2)Study completedNCT00001860
What this trial is testing

Sandostatin LAR Depot vs. Surgery for Treating Acromegaly

Who this might be right for
AcromegalyPituitary Neoplasm
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 5
Load More Results